Health ยท Pan-African

CEPI Commits Up to $8.2 Million to Boost Outbreak Trial Readiness in West Africa

CEPI's Research Preparedness Program has announced up to US$8.2 million in additional funding for the International Vaccine Institute and MRC Unit The Gambia at LSHTM. The money will support West Africa's part of Africa CDC's hub-and-spoke clinical trial model and strengthen emergency evidence generation.

CEPI's Research Preparedness Program has announced up to US$8.2 million in additional funding to support clinical trial readiness and emergency evidence generation in West Africa. The announcement was dated 26 October 2026 and issued from Oslo.

The money will go to the two Technical Coordinating Partners leading the programme's West Africa component: the International Vaccine Institute (IVI) and the Medical Research Council Unit The Gambia at the London School of Hygiene & Tropical Medicine (MRCG).

The funding is intended to support implementation of the hub-and-spoke clinical trial model of the Africa Centres for Disease Control and Prevention (Africa CDC). The programme aims to strengthen regional readiness for clinical trials so that evidence can be generated quickly during outbreaks.

The available information does not describe how the funds will be divided between the two partners, which countries or sites will take part, or what timeline applies to the work. It also does not name the diseases or pathogens the preparedness efforts will target.

More reporting from Voice of Africans